Error: Could not add to watchlist. X
+ Watchlist

Cymabay Therapeutics Inc

CBAY:US
NASDAQ CM
5.56
USD
0.43
8.38%
As of 8:10 PM EDT 6/23/2017
Open
5.39
Day Range
5.25 - 5.60
Volume
684,632
Previous Close
5.13
52Wk Range
1.15 - 5.60
1 Yr Return
210.61%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
5.39
Day Range
5.25 - 5.60
Volume
684,632
Previous Close
5.13
52Wk Range
1.15 - 5.60
1 Yr Return
210.61%
YTD Return
221.39%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.05
Market Cap (m USD)
159.864
Shares Outstanding (m)
28.752
Price/Sales (TTM)
30.87
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.09%
% Price Change
-0.13%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases.
Address
7999 Gateway Blvd
Suite 130
Newark, CA 94560
United States
Phone
1-510-293-8800
  • Robert J Wills "Rob"
    Chairman
  • Sujal Shah
    Interim Pres & CEO/CFO/Secy/Investor Relations
  • Pol F Boudes
    Chief Medical Officer
  • Charles A McWherter
    Senior VP/Chief Scientific Ofcr
  • Daniel Menold
    VP:Finance
Show More